Page last updated: 2024-08-26

1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole and Kahler Disease

1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole has been researched along with Kahler Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, X; Gao, H; Pan, J; Ren, Y; Tian, Y; Wang, L; Wang, W; Zhao, W1

Other Studies

1 other study(ies) available for 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole and Kahler Disease

ArticleYear
Orai1 and Stim1 Mediate the Majority of Store-Operated Calcium Entry in Multiple Myeloma and Have Strong Implications for Adverse Prognosis.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 48, Issue:6

    Topics: Adult; Aged; Apoptosis; Bone Marrow; Calcium; Calcium Channel Blockers; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Female; Humans; Imidazoles; Male; Middle Aged; Multiple Myeloma; Neoplasm Proteins; ORAI1 Protein; Prognosis; RNA Interference; RNA, Small Interfering; Stromal Interaction Molecule 1

2018